Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kyverna Therapeutics
Biotech
'Unprecedented' data prime Kyverna for 1st autoimmune CAR-T drug
Kyverna's CD19 CAR-T showed “unprecedented” results doctors have never seen with existing off-label therapies, the lead study investigator said.
Angus Liu
Dec 15, 2025 10:55am
Kyverna links CAR-T to autoimmune improvements in small trial
Oct 29, 2025 10:00am
Kyverna lays off 16% as autoimmune CAR-T plans take shape
May 14, 2025 6:30am
Flagship vet plants CEO roots at Pharming—Chutes & Ladders
Jan 24, 2025 8:30am
JPM25: Kyverna CEO sets priorities for CAR-T autoimmune biotech
Jan 13, 2025 7:30am
AI firm Xaira powers up C-suite with pharma vet—Chutes & Ladders
Dec 13, 2024 8:30am
